Literature DB >> 10500698

Rhabdomyolysis in heart transplant patients on HMG-CoA reductase inhibitors and cyclosporine.

J A Rodríguez1, M G Crespo-Leiro, M J Paniagua, J J Cuenca, L F Hermida, A Juffé, A Castro-Beiras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10500698     DOI： 10.1016/s0041-1345(99)00445-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

Review 3.  Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy.

Authors:  Robin Som; Peter J Morris; Simon R Knight
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

4.  Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand.

Authors:  Thananan Rattanachotphanit; Chulaporn Limwattananon; Onanong Waleekhachonloet
Journal:  Ther Adv Drug Saf       Date:  2019-01-30

5.  The role of statins in patients after heart transplantation.

Authors:  Bożena Szyguła-Jurkiewicz; Wioletta Szczurek; Marian Zembala
Journal:  Kardiochir Torakochirurgia Pol       Date:  2015-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.